What has Ohio published about peptides and compounding?
11 sentences from 3 documents that Ohio's own sources published name BPC-157, Semaglutide, Tirzepatide, Retatrutide, Cagrilintide, Testosterone, HCG. Each is below, as written, with where it came from and when we last read it.
OH pharmacy board: Ten Common Prescriber Clinic and Medical Spa Violations
Additionally, peptides such as BPC-157 and other bulk drug substances in category 2 and 3 (see FDA guidance ) cannot be compounded because it violates federal and state law.
OH pharmacy board: Ten Common Prescriber Clinic and Medical Spa Violations. Read it on the source · last read 2026-11-20
Names BPC-157.
Some common RUO drugs identified by Board inspectors include GLP-1s such as retatrutide and cagrilinitde that are not approved for use by the FDA and commercially available GLP-1s, such as semaglutide and tirzepatide.
OH pharmacy board: Ten Common Prescriber Clinic and Medical Spa Violations. Read it on the source · last read 2026-11-20
Names Retatrutide.
OH pharmacy board: compounding of GLP-1 drug products in Ohio
For outsourcing facilities compounding, distributing or dispensing semaglutide injection products under section 503B, FDA does not intend to take action for violations of the FD&C Act arising from conditions that depend on semaglutide injection productsʼ inclusion on FDAʼs drug shortage list until May 22, 2025.
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Semaglutide.
Therefore, consistent with FDAʼs March 10, 2025, update: For a state-licensed pharmacy or physician compounding, dispensing or distributing semaglutide injection products under section 503A of the FD&C Act, the period of enforcement discretion (described below) has ended.
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Semaglutide.
Can a prescriber clinic or compounding pharmacy continue to dispense or personally furnish compounded tirzepatide or semaglutide that was previously purchased prior to the end dates listed above?
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Semaglutide, Tirzepatide.
The following chart provides the status of GLP-1 drugs and the ability of Ohio pharmacies, prescribers, and outsourcing facilities to compound tirzepatide and semaglutide that are essentially copies of commercially available drug products: Name of Drug FDA Shortage?
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Semaglutide, Tirzepatide.
For more information on human drug compounding, visit: https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug- compounding The Ohio Board of Pharmacy (Board) has received inquiries concerning the compounding of GLP-1 medications such as semaglutide and tirzepatide.
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Semaglutide.
All inventory containing retatrutide or cagrilintide must be disposed of immediately.
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Retatrutide, Cagrilintide.
This does not apply to retatrutide or cagrilintide as these drugs are NOT FDA-approved.
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Retatrutide, Cagrilintide.
Retatrutide and/or Cagrilintide cannot be used in compounding under federal and state law.
OH pharmacy board: compounding of GLP-1 drug products in Ohio. Read it on the source · last read 2026-11-20
Names Retatrutide, Cagrilintide.
OH medical board (via official law host)
A physician shall not: (1) Utilize anabolic steroids, growth hormones, testosterone or its analogs, human chorionic gonadotropin ("HCG"), or other hormones for the purpose of enhancing athletic ability.
OH medical board (via official law host). Read it on the source · last read 2026-11-20
Names Testosterone, HCG.
What we read in Ohio
Board and laws, 4 of 4 sources answered, last read 2026-11-20.
- OH pharmacy board: compounding of GLP-1 drug products in Ohio
- OH pharmacy board: prescriber compounding guidance
- OH pharmacy board: Ten Common Prescriber Clinic and Medical Spa Violations
- OH medical board (via official law host)
- OH Administrative Code 4729:5-8-02, nonresident terminal distributors
- OH Revised Code 4729.54, terminal distributor licenses
- OH Board of Pharmacy: Joint Regulatory Statement (Medical, Pharmacy, Nursing) on Retail IV Therapy Clinics, 5/15/2025
The federal position on each peptide is on its own page, linked above.
We report what each source says, in its own words. We do not give legal advice. Nothing on record is not permission.